1-4 of 4
Kai Sun, MD, PhD
Close
Sort by
Journal Articles

ASXL1-Mutated Donor HSCs Evolved into FLT3-ITD Positive AML in the Unrelated Donor and FLT3-ITD Negative AML in the Recipient after Transplant

Zhongwen Liu, MD, Hongxing Liu, MD, Yanli Zhang, MD, Dai Kong, MD, Jie Shi, MD, Yin Zhang, MD, Meiying Wen, Yongping Song, MD PhD, Chunrong Tong, MD, Mingyi Chen, MD PhD, William J. Murphy, PhD, Kai Sun, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5403.
https://doi.org/10.1182/blood.V126.23.5403.5403
Published: 2015
Journal Articles

Removal of Donor CD4+ T Cells Markedly Promotes Graft-Versus-Tumor (GVT) Effects and Inhibits GVHD-Dependent Toxicity Associated with Prolonged Bortezomib Administration after Allogeneic BMT.

William J. Murphy, PhD, Lisbeth A. Welniak, PhD, Minghui Li, Thomas J. Sayers, PhD, Angela Panoskaltsis-Mortari, PhD, Bruce R. Blazar, MD, Kai Sun, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 3160.
https://doi.org/10.1182/blood.V108.11.3160.3160
Published: 2006
Journal Articles

Immunomodulatory Effects of the Triterpenoid CDDO after Allogeneic Bone Marrow Transplantation in Mice: Reduction of Acute Graft-Versus-Host Disease Lethality.

William J. Murphy, PhD, Olga Frolova, MD, Marina Konopleva, MD, PhD, Michael Andreeff, MD, PhD, Weihong Ma, MD, Danice Wilkins, Lisbeth A. Welniak, PhD, Kai Sun, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 1316.
https://doi.org/10.1182/blood.V106.11.1316.1316
Published: 2005
Journal Articles

Suppression of NK Cell-Mediated Bone Marrow Cell Rejection by CD4 + CD25 + Regulatory T Cells: Linkage of Adaptive to Innate Responses.

William J. Murphy, PhD, Isabel Bareo, PhD, Alan M. Hanash, PhD, Lisbeth A. Welniak, PhD, Kai Sun, MD, PhD, Bruce R. Blazar, MD, Robert B. Levy, PhD
Journal: Blood
Blood (2005) 106 (11): 2195.
https://doi.org/10.1182/blood.V106.11.2195.2195
Published: 2005